Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

Affiliations

• ¹ Hematology Service, Advanced Therapies in Oncohematology, IIS-IP, Hospital de la Princesa, Madrid, Spain. [email protected].
• ² Unitat d' Hematopatologia, Hospital Clinic, Barcelona, Spain.
• ³ Laboratorio de Hematología, Biología Molecular, Hospital Universitario de Gran Canaria Dr.Negrín, Las Palmas, Spain.
• ⁴ Servicio de Hematología, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
• ⁵ Hematology Department, Hospital Universitari Vall d'Hebron, VHIO, Barcelona, Spain.
• ⁶ Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, Spain.
• ⁷ Hematology Department, Imperial College Healthcare NHS Trust, London, UK.
• ⁸ Servicio de Hematología, Hospital Universitari Mútua Terrassa, Terrassa, Spain.
• ⁹ Instituto Investigación Sanitaria Aragón (IIS Aragon), CIBERER, Zaragoza, Spain.
• ¹⁰ Hematologia, Universidad de Cantabria, Santander, Spain.
• ¹¹ Servei d'Hematologia, ICO-Tarragona, Hospital Universitari Joan XXIII, Tarragona, Spain.
• ¹² Hematologia, Clínica de la Concepción, Madrid, Spain.
• ¹³ Hospital Clínico Universitario Lozano Blesa, Instituto Investigación (ISS) Aragón, Zaragoza, Spain.
• ¹⁴ Hematology Department, Hospital del Mar-IMIM, Barcelona, Spain.
• ¹⁵ Hematología, Departament de Salut d'Elx, Hospital General, Elche, Spain.
• ¹⁶ Hematología, Hospital Puerta de Hierro, Madrid, Spain.
• ¹⁷ Statistics Department, Dynamic Solutions, SL, Barcelona, Spain.
• ¹⁸ Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, USA.
• ¹⁹ Klinik für Innere Medizin II. Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany.
• ²⁰ Servicio de Hematología y Hemoterapia, Hospital Virgen de la Salud, Toledo, Spain.